CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 4.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $51,377 | -32.4% | 14,076 | -58.7% | 0.00% | – |
| Q3 2022 | $76,000 | -76.7% | 34,102 | -73.9% | 0.00% | -100.0% |
| Q2 2022 | $326,000 | -62.2% | 130,854 | -26.0% | 0.00% | -66.7% |
| Q1 2022 | $863,000 | +36.8% | 176,756 | +217.1% | 0.00% | +200.0% |
| Q4 2021 | $631,000 | -58.1% | 55,750 | -46.1% | 0.00% | -66.7% |
| Q3 2021 | $1,507,000 | -35.6% | 103,430 | -48.5% | 0.00% | -40.0% |
| Q2 2021 | $2,340,000 | -40.8% | 200,868 | -38.0% | 0.01% | -50.0% |
| Q1 2021 | $3,952,000 | -2.8% | 323,958 | -0.3% | 0.01% | -16.7% |
| Q4 2020 | $4,066,000 | -9.9% | 325,000 | +8.4% | 0.01% | -25.0% |
| Q3 2020 | $4,512,000 | -21.1% | 299,817 | +28.4% | 0.02% | -42.9% |
| Q2 2020 | $5,722,000 | – | 233,451 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,545,573 | $3,447,000 | 1.85% |
| P.A.W. CAPITAL CORP | 200,000 | $446,000 | 0.67% |
| SANDERS MORRIS HARRIS LLC | 848,048 | $2,020,000 | 0.50% |
| Monaco Asset Management SAM | 458,851 | $1,023,000 | 0.39% |
| Bleichroeder LP | 555,000 | $1,238,000 | 0.26% |
| APOGEM CAPITAL LLC | 110,614 | $247,000 | 0.25% |
| Slate Path Capital LP | 1,483,619 | $3,308,000 | 0.22% |
| Voss Capital, LLC | 200,000 | $446,000 | 0.13% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $1,067,000 | 0.11% |
| CARLSON CAPITAL L P | 535,000 | $1,193,000 | 0.09% |